US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 39.891
  • -1.269-3.08%
Trading Dec 30 09:48 ET
4.45BMarket Cap-42.44P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
-45.63%-19.66M
14.93%-11.44M
-134.03%-24.64M
-1.70%-48.4M
11.53%-10.93M
Net income from continuing operations
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
-42.86%-22.53M
-10.29%-19.23M
-21.29%-19.53M
-25.24%-68.87M
-58.30%-19.56M
Operating gains losses
---113K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
19.18%87K
2.74%75K
2.78%74K
0.34%292K
2.78%74K
-48.59%73K
--73K
-6.49%72K
-1.69%291K
-5.26%72K
Other non cash items
175.00%33K
-37.21%27K
-7.50%37K
31.00%131K
80.00%36K
-76.92%12K
258.33%43K
150.00%40K
244.83%100K
66.67%20K
Change In working capital
-170.93%-1.03M
-259.62%-8.01M
289.80%15.95M
-65.18%3.55M
-15.48%5.48M
48,600.00%1.46M
298.73%5.02M
-442.60%-8.4M
448.10%10.19M
385.46%6.48M
-Change in receivables
447.56%1.35M
-134.33%-157K
169.55%655K
-47.72%321K
-187.83%-101K
62.91%246K
-127.57%-67K
131.43%243K
-47.79%614K
-80.64%115K
-Change in prepaid assets
-298.69%-2.73M
-101.07%-79K
177.41%1.75M
304.73%6.41M
95.95%-58K
66.83%1.37M
388.95%7.35M
-9,917.39%-2.26M
-340.23%-3.13M
-366.45%-1.43M
-Change in payables and accrued expense
677.92%445K
-253.26%-7.69M
316.31%13.64M
-121.98%-2.83M
-27.38%5.72M
91.10%-77K
-162.58%-2.18M
-362.56%-6.3M
522.75%12.89M
418.94%7.88M
-Change in other current liabilities
-10.34%-96K
-2.27%-90K
-3.53%-88K
-83.60%-347K
-3.57%-87K
22.32%-87K
-206.02%-88K
-11.84%-85K
44.74%-189K
2.33%-84K
Cash from discontinued investing activities
Operating cash flow
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
-45.63%-19.66M
14.93%-11.44M
-134.03%-24.64M
-1.70%-48.4M
11.53%-10.93M
Investing cash flow
Cash flow from continuing investing activities
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
-146.61%-12.53M
-1,177.36%-204.48M
35.76%2.2M
44.24%54.75M
-73.51%7.26M
Net investment purchase and sale
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
-146.61%-12.53M
-1,177.36%-204.48M
35.76%2.2M
44.24%54.75M
-73.51%7.26M
Cash from discontinued investing activities
Investing cash flow
306.65%25.9M
38.35%-126.06M
-21,018.65%-459.79M
-427.08%-179.09M
392.19%35.73M
-146.61%-12.53M
-1,177.36%-204.48M
35.76%2.2M
44.24%54.75M
-73.51%7.26M
Financing cash flow
Cash flow from continuing financing activities
3,508.11%2.52M
-98.91%2.91M
14,384.63%606.04M
6,418.76%271.38M
-98.25%188K
-840.00%-74K
16,897.36%267.08M
183.58%4.18M
-39.49%4.16M
22,770.21%10.75M
Net common stock issuance
2,360.86%46.66M
-100.01%-25K
1,613,935.14%597.12M
--0
-2,717,190.00%-271.73M
18,860.00%1.9M
16,221.27%269.87M
99.28%-37K
---6.8M
---10K
Proceeds from stock option exercised by employees
252,300.00%2.52M
12.05%2.93M
9.96%4.36M
698.11%6.77M
25.33%188K
---1K
3,013.10%2.62M
545.93%3.97M
-88.89%848K
127.27%150K
Net other financing activities
-2,269.63%-46.66M
--0
1,687.06%4.56M
2,517.29%264.61M
2,461.31%271.73M
---1.97M
---5.41M
151.10%255K
1,442.63%10.11M
55,936.84%10.61M
Cash from discontinued financing activities
Financing cash flow
3,508.11%2.52M
-98.91%2.91M
14,384.63%606.04M
6,418.76%271.38M
-98.25%188K
-840.00%-74K
16,897.36%267.08M
183.58%4.18M
-39.49%4.16M
22,770.21%10.75M
Net cash flow
Beginning cash position
-36.83%43.92M
965.13%195.58M
51.55%55.52M
38.91%36.63M
26.45%37.19M
328.44%69.52M
47.44%18.36M
38.91%36.63M
-9.43%26.37M
161.08%29.41M
Current changes in cash
120.02%6.46M
-396.46%-151.67M
867.27%140.11M
79.81%18.91M
158.10%18.28M
-340.70%-32.27M
1,195.85%51.16M
-31.21%-18.26M
483.07%10.52M
-53.11%7.08M
Effect of exchange rate changes
57.35%-29K
200.00%3K
-433.33%-48K
88.37%-30K
-64.54%50K
69.51%-68K
98.30%-3K
---9K
---258K
--141K
End cash Position
35.40%50.35M
-36.83%43.92M
965.13%195.58M
51.55%55.52M
51.55%55.52M
26.45%37.19M
328.44%69.52M
47.44%18.36M
38.91%36.63M
38.91%36.63M
Free cash flow
-11.72%-21.96M
-149.35%-28.51M
75.11%-6.13M
-51.61%-73.38M
-61.45%-17.64M
-45.63%-19.66M
14.93%-11.44M
-134.03%-24.64M
-1.70%-48.4M
11.53%-10.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M-45.63%-19.66M14.93%-11.44M-134.03%-24.64M-1.70%-48.4M11.53%-10.93M
Net income from continuing operations -10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M-42.86%-22.53M-10.29%-19.23M-21.29%-19.53M-25.24%-68.87M-58.30%-19.56M
Operating gains losses ---113K------------------------------------
Depreciation and amortization 19.18%87K2.74%75K2.78%74K0.34%292K2.78%74K-48.59%73K--73K-6.49%72K-1.69%291K-5.26%72K
Other non cash items 175.00%33K-37.21%27K-7.50%37K31.00%131K80.00%36K-76.92%12K258.33%43K150.00%40K244.83%100K66.67%20K
Change In working capital -170.93%-1.03M-259.62%-8.01M289.80%15.95M-65.18%3.55M-15.48%5.48M48,600.00%1.46M298.73%5.02M-442.60%-8.4M448.10%10.19M385.46%6.48M
-Change in receivables 447.56%1.35M-134.33%-157K169.55%655K-47.72%321K-187.83%-101K62.91%246K-127.57%-67K131.43%243K-47.79%614K-80.64%115K
-Change in prepaid assets -298.69%-2.73M-101.07%-79K177.41%1.75M304.73%6.41M95.95%-58K66.83%1.37M388.95%7.35M-9,917.39%-2.26M-340.23%-3.13M-366.45%-1.43M
-Change in payables and accrued expense 677.92%445K-253.26%-7.69M316.31%13.64M-121.98%-2.83M-27.38%5.72M91.10%-77K-162.58%-2.18M-362.56%-6.3M522.75%12.89M418.94%7.88M
-Change in other current liabilities -10.34%-96K-2.27%-90K-3.53%-88K-83.60%-347K-3.57%-87K22.32%-87K-206.02%-88K-11.84%-85K44.74%-189K2.33%-84K
Cash from discontinued investing activities
Operating cash flow -11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M-45.63%-19.66M14.93%-11.44M-134.03%-24.64M-1.70%-48.4M11.53%-10.93M
Investing cash flow
Cash flow from continuing investing activities 306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M-146.61%-12.53M-1,177.36%-204.48M35.76%2.2M44.24%54.75M-73.51%7.26M
Net investment purchase and sale 306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M-146.61%-12.53M-1,177.36%-204.48M35.76%2.2M44.24%54.75M-73.51%7.26M
Cash from discontinued investing activities
Investing cash flow 306.65%25.9M38.35%-126.06M-21,018.65%-459.79M-427.08%-179.09M392.19%35.73M-146.61%-12.53M-1,177.36%-204.48M35.76%2.2M44.24%54.75M-73.51%7.26M
Financing cash flow
Cash flow from continuing financing activities 3,508.11%2.52M-98.91%2.91M14,384.63%606.04M6,418.76%271.38M-98.25%188K-840.00%-74K16,897.36%267.08M183.58%4.18M-39.49%4.16M22,770.21%10.75M
Net common stock issuance 2,360.86%46.66M-100.01%-25K1,613,935.14%597.12M--0-2,717,190.00%-271.73M18,860.00%1.9M16,221.27%269.87M99.28%-37K---6.8M---10K
Proceeds from stock option exercised by employees 252,300.00%2.52M12.05%2.93M9.96%4.36M698.11%6.77M25.33%188K---1K3,013.10%2.62M545.93%3.97M-88.89%848K127.27%150K
Net other financing activities -2,269.63%-46.66M--01,687.06%4.56M2,517.29%264.61M2,461.31%271.73M---1.97M---5.41M151.10%255K1,442.63%10.11M55,936.84%10.61M
Cash from discontinued financing activities
Financing cash flow 3,508.11%2.52M-98.91%2.91M14,384.63%606.04M6,418.76%271.38M-98.25%188K-840.00%-74K16,897.36%267.08M183.58%4.18M-39.49%4.16M22,770.21%10.75M
Net cash flow
Beginning cash position -36.83%43.92M965.13%195.58M51.55%55.52M38.91%36.63M26.45%37.19M328.44%69.52M47.44%18.36M38.91%36.63M-9.43%26.37M161.08%29.41M
Current changes in cash 120.02%6.46M-396.46%-151.67M867.27%140.11M79.81%18.91M158.10%18.28M-340.70%-32.27M1,195.85%51.16M-31.21%-18.26M483.07%10.52M-53.11%7.08M
Effect of exchange rate changes 57.35%-29K200.00%3K-433.33%-48K88.37%-30K-64.54%50K69.51%-68K98.30%-3K---9K---258K--141K
End cash Position 35.40%50.35M-36.83%43.92M965.13%195.58M51.55%55.52M51.55%55.52M26.45%37.19M328.44%69.52M47.44%18.36M38.91%36.63M38.91%36.63M
Free cash flow -11.72%-21.96M-149.35%-28.51M75.11%-6.13M-51.61%-73.38M-61.45%-17.64M-45.63%-19.66M14.93%-11.44M-134.03%-24.64M-1.70%-48.4M11.53%-10.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+0.79%
Petroleo Brasileiro SA Petrobras
PBR
+0.64%
Vale SA
VALE
+0.06%
Taylor Morrison Home
TMHC
-0.82%
Adobe
ADBE
-0.94%

Unlock the Full List

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-1.27%